UDP trisodium (Compound 3) is a nucleotide and a P2Y14 receptor agonist, exhibiting an EC50 of 160 nM for the human P2Y14 receptor. It demonstrates greater efficacy compared to the P2Y6 receptor and is utilized in researching pain, diabetes, cystic fibrosis, and other pulmonary disorders.
Target:
P2Y Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
